Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Product Type (Hemostats (Thrombin Based, Combination Hemostats, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based), Internal Tissue Sealants (Fibrin Based, Co

Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Product Type (Hemostats (Thrombin Based, Combination Hemostats, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based), Internal Tissue Sealants (Fibrin Based, Collagen Based, Protein Based, Synthetic Polymer Based), Adhesion Barriers (Film Based, Gel Based, Solution Based)), By Application (Surgical Applications (Cardiovascular Surgeries, Neurological Surgeries, Orthopedic Surgeries, Urological & Gynecological Surgeries, General Surgeries, Reconstructive and Plastic Surgeries, Others), Trauma Cases), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Surgical hemostats, internal tissue sealants, and adhesion barriers are medical procedures/devices used to control bleeding after injuries, and during surgical procedures. Hemostats, also referred to as hemostatic clamp, arterial forceps or pean are surgical tools used in surgical procedures to control bleeding. The hemostats were designed to clamp blood vessels of small size to manage blood flow in hemorrhagic cases. These devices are also used to grasp and secure superficial fascia during wound closure surgical procedures. The hemostats, with hinges and rings, are visibly similar to scissors.
Restraints of the Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market
The high cost involved in R&D of surgical hemostats, internal tissue sealants, and adhesion barriers technology-based products and limited financial support has posed a great challenge to growth of the global surgical hemostats, internal tissue sealants, and adhesion barriers market.
Key features of the study:
This report provides in-depth analysis of the global surgical hemostats, internal tissue sealants, and adhesion barriers market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global surgical hemostats, internal tissue sealants, and adhesion barriers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Ethicon (Johnson & Johnson), Baxter International Inc., Integra LifeSciences Holdings Corporation, Pfizer Inc., Tissuemed Ltd., Sanofi, Braun Melsungen AG, C.R. Bard, Inc., CryoLife, Inc., Cohera Medical, Inc., and CSL Behring
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global surgical hemostats, internal tissue sealants, and adhesion barriers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Product Type:
Hemostats
Thrombin Based
Combination Hemostats
Oxidized Regenerated Cellulose Based
Gelatin Based
Collagen Based
Internal Tissue Sealants
Fibrin Based
Collagen Based
Protein Based
Synthetic Polymer Based
Adhesion Barriers
Film Based
Gel Based
Solution Based
Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Application:
Surgical Applications
Cardiovascular Surgeries
Neurological Surgeries
Orthopedic Surgeries
Urological & Gynecological Surgeries
General Surgeries
Reconstructive and Plastic Surgeries
Others
Trauma Cases
Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Geography:
North America
By Product Type
Hemostats
Thrombin Based
Combination Hemostats
Oxidized Regenerated Cellulose Based
Gelatin Based
Collagen Based
Internal Tissue Sealants
Fibrin Based
Collagen Based
Protein Based
Synthetic Polymer Based
Adhesion Barriers
Film Based
Gel Based
Solution Based
By Application
Surgical Applications
Cardiovascular Surgeries
Neurological Surgeries
Orthopedic Surgeries
Urological & Gynecological Surgeries
General Surgeries
Reconstructive and Plastic Surgeries
Others
Trauma Case
By End User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Country:
U.S.
Canada
Europe
By Product Type
Hemostats
Thrombin Based
Combination Hemostats
Oxidized Regenerated Cellulose Based
Gelatin Based
Collagen Based
Internal Tissue Sealants
Fibrin Based
Collagen Based
Protein Based
Synthetic Polymer Based
Adhesion Barriers
Film Based
Gel Based
Solution Based
By Application
Surgical Applications
Cardiovascular Surgeries
Neurological Surgeries
Orthopedic Surgeries
Urological & Gynecological Surgeries
General Surgeries
Reconstructive and Plastic Surgeries
Others
Trauma Case
By End User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type
Hemostats
Thrombin Based
Combination Hemostats
Oxidized Regenerated Cellulose Based
Gelatin Based
Collagen Based
Internal Tissue Sealants
Fibrin Based
Collagen Based
Protein Based
Synthetic Polymer Based
Adhesion Barriers
Film Based
Gel Based
Solution Based
By Application
Surgical Applications
Cardiovascular Surgeries
Neurological Surgeries
Orthopedic Surgeries
Urological & Gynecological Surgeries
General Surgeries
Reconstructive and Plastic Surgeries
Others
Trauma Case
By End User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type
Hemostats
Thrombin Based
Combination Hemostats
Oxidized Regenerated Cellulose Based
Gelatin Based
Collagen Based
Internal Tissue Sealants
Fibrin Based
Collagen Based
Protein Based
Synthetic Polymer Based
Adhesion Barriers
Film Based
Gel Based
Solution Based
By Application
Surgical Applications
Cardiovascular Surgeries
Neurological Surgeries
Orthopedic Surgeries
Urological & Gynecological Surgeries
General Surgeries
Reconstructive and Plastic Surgeries
Others
Trauma Case
By End User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Product Type
Hemostats
Thrombin Based
Combination Hemostats
Oxidized Regenerated Cellulose Based
Gelatin Based
Collagen Based
Internal Tissue Sealants
Fibrin Based
Collagen Based
Protein Based
Synthetic Polymer Based
Adhesion Barriers
Film Based
Gel Based
Solution Based
By Application
Surgical Applications
Cardiovascular Surgeries
Neurological Surgeries
Orthopedic Surgeries
Urological & Gynecological Surgeries
General Surgeries
Reconstructive and Plastic Surgeries
Others
Trauma Case
By End User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type
Hemostats
Thrombin Based
Combination Hemostats
Oxidized Regenerated Cellulose Based
Gelatin Based
Collagen Based
Internal Tissue Sealants
Fibrin Based
Collagen Based
Protein Based
Synthetic Polymer Based
Adhesion Barriers
Film Based
Gel Based
Solution Based
By Application
Surgical Applications
Cardiovascular Surgeries
Neurological Surgeries
Orthopedic Surgeries
Urological & Gynecological Surgeries
General Surgeries
Reconstructive and Plastic Surgeries
Others
Trauma Case
By End User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Ethicon (Johnson & Johnson)*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Baxter International Inc.
Integra LifeSciences Holdings Corporation
Pfizer Inc.
Tissuemed Ltd.
Sanofi
Braun Melsungen AG
C.R. Bard, Inc.
CryoLife, Inc.
Cohera Medical, Inc.
CSL Behring
“*” marked represents similar segmentation in other categories in the respective section.